Countless headlines emerged this week chronicling global outbreaks of a mysterious liver disease. Children worldwide are being hospitalized with severe symptoms including abdominal pain, respiratory complications, jaundice, diarrhea, and vomiting. Since April 21st there have been nearly 200 cases and several fatalities. Approximately 10% require a liver transplant. Strangely, patients tested negative for typical hepatitis strains including A, B, C, D, and E. World Health Organization representatives announced the surging illness is inexplicable. However, recently released court-ordered Pfizer documents provide further insight into the connection between COVID-19 inoculations and potential liver damage.
Vaccines Accumulate in the Liver
Last year pharmaceutical delegates repeatedly affirmed coronavirus vaccines did not leave the injection site. Yet it’s now clear these statements were not mere ignorance but blatant misinformation. Dossiers from January of 2021 detail concerning animal testing results. Scientists discovered immunizations migrate within 48 hours of administration. Ingredients quickly spread throughout recipients’ bodies. Areas affected include the adrenal glands, bladder, eyes, bone marrow, intestines, thymus, pancreas, salivary glands, lymph nodes, thyroid, testes, uterus, and pancreas. Significant acclimation of injection contents took place in the ovaries (.09%), spleen (1.03%), and liver (16.2%). Aggregation of synthetic materials inside organs can generate a host of physical ailments.
Startling Evidence Surfaces
Pfizers’ clinical trials weren’t the only perturbing findings uncovered by physicians. Dr. Stephanie Seneff, a senior researcher at the Massachusetts Institute of Technology, tediously studied SARS-CoV-2 vaccines. She observed a direct correlation between the experimental jabs and autoimmune hepatitis. Controlled assessments indicate each dose can trigger a variety of maladies. Seneff concluded: “We present evidence that vaccination induces a profound impairment in type I interferon signaling, which has diverse adverse consequences to human health. Immune cells that have taken up the vaccine nanoparticles release into circulation large numbers of exosomes containing spike protein along with critical microRNAs that induce a signaling response in recipient cells at distant sites. We also identify potential profound disturbances in the regulatory control of protein synthesis and cancer surveillance. These disturbances potentially have a causal link to neurodegenerative disease, myocarditis, immune thrombocytopenia, Bell’s palsy, liver disease, impaired adaptive immunity, impaired DNA damage response, and tumorigenesis.”
Numerous papers from the United States National Library of Medicine corroborate these assertions. One journal entry labeled SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis describes a similar phenomenon. Authors write: “Analysis of the hepatic tissue revealed an immune infiltrate quantitatively dominated by activated cytotoxic CD8 T cells with panlobular distribution. COVID-19 vaccination can elicit a distinct T cell-dominant immune-mediated hepatitis with a unique pathomechanism associated with vaccination-induced antigen-specific tissue-resident immunity requiring systemic immunosuppression.” Another group of academics produced a publication titled Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line. They conducted the first in vitro study on the effects of COVID-19 BNT162b2 vaccines on the human liver cell line. Examined data reveals mRNA can be reverse-transcribed into DNA in the liver.
VAERS, an online archive of adverse reactions, identified 731 individuals who developed serious liver problems following coronavirus shots. Harvard statisticians estimate less than 1% of all incidents are ever reported. As such, the true numbers could be exponentially higher. Federal agencies continue to insist the gene-altering infusions are ‘safe and effective’. Big Pharma has done everything in its power to conceal detrimental side effects from prospective customers. Given the unprecedented influx of hepatitis-like conditions in young people, we must begin asking difficult questions. Further investigations are necessary to better assist those who are currently suffering.